Acetazolamide Injection, Powder, For Solution
Product Images NDC 25021-839

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 25021-839). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ace19 0000 01)

Chemical structure of Acetazolamide Sodium, showing the molecular arrangement including sulfonamide, acetamide, and heterocyclic components.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ace19 0000 02)

Acetazolamide 500 mg per vial injection powder label for intravenous use, manufactured by Sagent Pharmaceuticals. The label indicates it is a single-dose vial for USP injection, preservative-free, with storage instructions between 20° to 25°C. It also includes the NDC 25021-839-20, manufacturer details, and space for lot and expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.